MiR-214-3p can inhibit the cell viability and development of colon cancer by inhibiting ADP-ribosylation factor-like protein 2 (ARL2) and mitochondrial transcription factor A (TFAM) (Long et al., 2015; Wu et al., 2018a; Wu et al., 2018b). Here, ARL2 is linked to colonic neoplasm.